Products for Research Use Only
RegisterLogin

SB202190

CAT: 0400-SIH-473-5MGSize: 5 mgDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0400-SIH-473-5MGSize:5 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Background
SB202190 is a highly selective and potent inhibitor of p38 MAP kinase. Specifically, it binds within the ATP pocket of the active kinase and selectively inhibits the p38α and β isoforms. It has been shown to induce apoptosis. SB202190 is cell-permeable.
Description
P38 MAP kinase inhibitor
CAS Number
152121-30-7
Product Name Alternative
FHPI, 4- (4-Fluorophenyl) -2- (4-hydroxyphenyl) -5- (4-pyridyl) -1H-imidazole
UNSPSC
41116105
Type
Inhibitor
Source
Synthetic
Field of Research
Cell Signaling | Cancer | Apoptosis | Cancer Growth Inhibitors | Tyrosine Kinase Inhibitors
Purity
≥98% (TLC)
Weight
0.005
Format
Pale yellow solid
Solubility
Soluble in methanol, DMSO or acetone; slightly soluble in ethyl acetate
Molecular Formula
C20H14FN3O
Molecular Weight
331.3
Precautions
Not for use in humans. Not for use in diagnostics or therapeutics. For in vitro research use only.
References & Citations
1. Nemoto S., Xiang J., Huang S., & Lin A. (1998) J. Bio. Chem. 273(26): 16415–16420. 2. Karahashi H., Nagata K., Ishii K., & Amano F. (2000) Biochimica Et Biophysica Acta. 1502(2): 207–223.

Alternative Products

CatalogName
MBS808173-01SB202190
A1632-SSB202190 (FHPI)
ALX-270-268-M005SB202190 . hydrochloride
sc-222294SB202190 hydrochloride
PB180610SB202190 Solution (100 mM)
SC0380-10mMSB202190 (p38 MAPK inhibitor)
MBS6023840-01SB202190 (FHPI, 4-(4-Fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)-1H-imidazole)
045271-01SB202190 (FHPI, 4- (4-Fluorophenyl) -2- (4-hydroxyphenyl) -5- (4-pyridyl) -1H-imidazole)

Popular Products